Literature DB >> 10448802

Prethrombotic disorders in children with arterial ischemic stroke and sinovenous thrombosis.

M Bonduel1, G Sciuccati, M Hepner, A F Torres, G Pieroni, J P Frontroth.   

Abstract

BACKGROUND: Arterial ischemic stroke (AIS) and sinovenous thrombosis (SVT) are relatively rare events in children. The contribution of prethrombotic disorders to the etiology of these entities has not been completely elucidated.
OBJECTIVES: To determine the frequency of inherited and acquired prethrombotic disorders in a pediatric population with AIS and SVT and to report clinical and radiological features.
METHODS: From May 1992 to April 1997, 30 consecutive children with AIS and 10 children with SVT were assisted at a single institution. Hemostatic evaluation was performed for all the children. Evaluation included the following assays: protein C, protein S, antithrombin, plasminogen, activated protein C resistance, factor V Leiden mutation, and the detection of antiphospholipid antibodies. Data concerning baseline demographics, risk factors, presenting features, family history of thrombosis, and radiological findings were also recorded.
RESULTS: One or more prethrombotic disorders were present in 9 children (30%) with AIS (inherited protein S deficiency, 2 patients; inherited protein C deficiency, 1 patient; acquired antithrombin deficiency, 2 patients; antiphospholipid antibodies, 3 patients; and antiphospholipid antibodies and plaminogen deficiency, 1 patient) and in 5 children (50%) with SVT (inherited protein S deficiency, 1 patient; acquired antithrombin deficiency, 3 patients; and antiphospholipid antibodies, 1 patient).
CONCLUSIONS: Most children studied presented both a variety of risk factors for thrombosis and concomitant prethrombotic disorders. Therefore, a complete hemostatic evaluation for all children with AIS and SVT should be performed, despite the presence of obvious clinical risk factors or lack of family history of thrombosis.

Entities:  

Mesh:

Year:  1999        PMID: 10448802     DOI: 10.1001/archneur.56.8.967

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  7 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Pediatric stroke.

Authors:  Javier F Cárdenas; Jong M Rho; Adam Kirton
Journal:  Childs Nerv Syst       Date:  2011-02-20       Impact factor: 1.475

Review 3.  Antithrombotic drug treatment of pediatric patients with ischemic stroke.

Authors:  Ulrike Nowak-Göttl; Ronald Sträeter; Guillaume Sébire; Fenella Kirkham
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 4.  Inherited and acquired risk factors for arterial ischemic stroke in childhood.

Authors:  Giuseppe Lippi; Massimo Franchini; Martina Montagnana; Gian Luca Salvagno; Giovanni Targher; Gian Cesare Guidi
Journal:  J Thromb Thrombolysis       Date:  2008-02-10       Impact factor: 2.300

5.  Pediatric stroke: a review.

Authors:  Daniel S Tsze; Jonathan H Valente
Journal:  Emerg Med Int       Date:  2011-12-27       Impact factor: 1.112

6.  Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study.

Authors:  Gili Kenet; Fenella Kirkham; Thomas Niederstadt; Achim Heinecke; Dawn Saunders; Monika Stoll; Benjamin Brenner; Christoph Bidlingmaier; Christine Heller; Ralf Knöfler; Rosemarie Schobess; Barbara Zieger; Guillaume Sébire; Ulrike Nowak-Göttl
Journal:  Lancet Neurol       Date:  2007-07       Impact factor: 44.182

7.  Cerebral Venous Sinus Thrombosis due to Iron Deficiency Anemia in an Adolescent Girl.

Authors:  Hussein N Matlik; Nivargi Sagar
Journal:  Case Rep Pediatr       Date:  2021-07-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.